032300 — Korea Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Korea Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	62,540	64,076	51,953	38,725	27,530
Net Total Accounts Receivable
Net Total Receivables	17,598	16,419	14,624	15,542	14,443
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	97,236	98,083	85,385	73,634	64,369
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20,149	22,130	23,534	24,010	22,914
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	129,401	130,947	121,303	112,387	126,640
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,498	69,535	33,300	19,321	56,568
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	71,934	71,132	52,722	40,946	57,854
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	57,467	59,815	68,582	71,441	68,786
Total Liabilities & Shareholders' Equity	129,401	130,947	121,303	112,387	126,640
Total Common Shares Outstanding